News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Conference News CRT 2019 CABG vs PCI in Left Main Disease: The Debate Continues Yael L. Maxwell March 12, 2019
News Conference News CRT 2019 New ALERTS Data Support Use of Implantable Cardiac Monitor in High-Risk ACS Patients—With Caveats Yael L. Maxwell March 03, 2019